Cargando…

Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT)

Background Musculoskeletal pain is the most common complaint presented to the health practitioner. It is well-known that untreated or under-treated pain can have a significant negative impact on an individual’s quality of life (QoL). Objectives The current study aimed to assess the clinical response...

Descripción completa

Detalles Bibliográficos
Autores principales: Noor, Syed Shahid, Najjad, Muhammad Kazim, Ahmed, Nasir, Anwar, Khurram, Memon, Abdul, Riaz, Tehseen, Hanif, Muhammad, Maqbool, Nauman, Ahmed, Saeed, Ahmed, Israr, Khanzada, Ali Yasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994056/
https://www.ncbi.nlm.nih.gov/pubmed/35415025
http://dx.doi.org/10.7759/cureus.23011
_version_ 1784684028832514048
author Noor, Syed Shahid
Najjad, Muhammad Kazim
Ahmed, Nasir
Anwar, Khurram
Memon, Abdul
Riaz, Tehseen
Hanif, Muhammad
Maqbool, Nauman
Ahmed, Saeed
Ahmed, Israr
Khanzada, Ali Yasir
author_facet Noor, Syed Shahid
Najjad, Muhammad Kazim
Ahmed, Nasir
Anwar, Khurram
Memon, Abdul
Riaz, Tehseen
Hanif, Muhammad
Maqbool, Nauman
Ahmed, Saeed
Ahmed, Israr
Khanzada, Ali Yasir
author_sort Noor, Syed Shahid
collection PubMed
description Background Musculoskeletal pain is the most common complaint presented to the health practitioner. It is well-known that untreated or under-treated pain can have a significant negative impact on an individual’s quality of life (QoL). Objectives The current study aimed to assess the clinical response of Nuberol Forte® (paracetamol 650 mg + orphenadrine 50 mg) to musculoskeletal pain in routine Pakistani practice and its impact on improving the patient’s QoL. Methods A prospective, observational multicenter study (NFORT-EFFECT: Safety & Efficacy of Nuberol Forte in Pain Management). Three hundred ninety-nine patients with known prescreened musculoskeletal pain were recruited from 10 major healthcare facilities across six (6) major cities of Pakistan, as per the inclusion/exclusion criteria. After the baseline visit (Visit 1), the patients were followed up one to two weeks (Visit 2) after the treatment as per the physician's discretion. Data were collected using the Case Report Form (CRF) designed for the study, and adverse events (AEs) were also monitored to assess drug safety. Pain intensity was assessed through a visual analog scale (VAS), and QoL was assessed using the Muscle and Joint Measure (MJM) scale. Results Out of 399 enrolled patients, 49.4% were males and 50.6% were females with a mean age of 47.24 ± 14.20 years. Most patients were presented with knee osteoarthritis (OA), i.e., 148 (38%), followed by backache 70 (18.2%). A significant reduction in the mean pain score was observed after treatment with the combination of paracetamol and orphenadrine (p<0.05). Furthermore, an overall improvement in the patient’s QoL was also observed. During the study, only 10 patients reported mild adverse events (AEs), namely, dryness of the mouth, dizziness, gastric irritation, tachycardia, restlessness, etc. Conclusion The combination of paracetamol and orphenadrine (Nuberol Forte) exhibited effective pain management among patients with musculoskeletal conditions and improved their QoL.
format Online
Article
Text
id pubmed-8994056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-89940562022-04-11 Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT) Noor, Syed Shahid Najjad, Muhammad Kazim Ahmed, Nasir Anwar, Khurram Memon, Abdul Riaz, Tehseen Hanif, Muhammad Maqbool, Nauman Ahmed, Saeed Ahmed, Israr Khanzada, Ali Yasir Cureus Pain Management Background Musculoskeletal pain is the most common complaint presented to the health practitioner. It is well-known that untreated or under-treated pain can have a significant negative impact on an individual’s quality of life (QoL). Objectives The current study aimed to assess the clinical response of Nuberol Forte® (paracetamol 650 mg + orphenadrine 50 mg) to musculoskeletal pain in routine Pakistani practice and its impact on improving the patient’s QoL. Methods A prospective, observational multicenter study (NFORT-EFFECT: Safety & Efficacy of Nuberol Forte in Pain Management). Three hundred ninety-nine patients with known prescreened musculoskeletal pain were recruited from 10 major healthcare facilities across six (6) major cities of Pakistan, as per the inclusion/exclusion criteria. After the baseline visit (Visit 1), the patients were followed up one to two weeks (Visit 2) after the treatment as per the physician's discretion. Data were collected using the Case Report Form (CRF) designed for the study, and adverse events (AEs) were also monitored to assess drug safety. Pain intensity was assessed through a visual analog scale (VAS), and QoL was assessed using the Muscle and Joint Measure (MJM) scale. Results Out of 399 enrolled patients, 49.4% were males and 50.6% were females with a mean age of 47.24 ± 14.20 years. Most patients were presented with knee osteoarthritis (OA), i.e., 148 (38%), followed by backache 70 (18.2%). A significant reduction in the mean pain score was observed after treatment with the combination of paracetamol and orphenadrine (p<0.05). Furthermore, an overall improvement in the patient’s QoL was also observed. During the study, only 10 patients reported mild adverse events (AEs), namely, dryness of the mouth, dizziness, gastric irritation, tachycardia, restlessness, etc. Conclusion The combination of paracetamol and orphenadrine (Nuberol Forte) exhibited effective pain management among patients with musculoskeletal conditions and improved their QoL. Cureus 2022-03-09 /pmc/articles/PMC8994056/ /pubmed/35415025 http://dx.doi.org/10.7759/cureus.23011 Text en Copyright © 2022, Noor et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pain Management
Noor, Syed Shahid
Najjad, Muhammad Kazim
Ahmed, Nasir
Anwar, Khurram
Memon, Abdul
Riaz, Tehseen
Hanif, Muhammad
Maqbool, Nauman
Ahmed, Saeed
Ahmed, Israr
Khanzada, Ali Yasir
Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT)
title Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT)
title_full Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT)
title_fullStr Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT)
title_full_unstemmed Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT)
title_short Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT)
title_sort clinical response of nuberol forte® for pain management with musculoskeletal conditions in routine pakistani practice (nforte-effect)
topic Pain Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994056/
https://www.ncbi.nlm.nih.gov/pubmed/35415025
http://dx.doi.org/10.7759/cureus.23011
work_keys_str_mv AT noorsyedshahid clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT najjadmuhammadkazim clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT ahmednasir clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT anwarkhurram clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT memonabdul clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT riaztehseen clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT hanifmuhammad clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT maqboolnauman clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT ahmedsaeed clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT ahmedisrar clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect
AT khanzadaaliyasir clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect